Steve Crouse
Equibles does not estimate personal net worth.
Get an email with a short summary when BIO-TECHNE Corp publishes a filing, an earnings call transcript or a press release.
Get TECH alertsAbout Steve Crouse
BIO-TECHNE Corp reported in an 8-K filed February 11, 2026 that Steve Crouse was appointed President, Diagnostics and Spatial Biology Segment, effective March 1, 2026. BIO-TECHNE Corp is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at BIO-TECHNE Corp includes Charles Kummeth (CEO), James T. Hippel (CFO), Kim Kelderman (COO and Board Member) and 7 others.
“the Company announced the appointment of Mr. Steve Crouse, age 52, as President, Diagnostics and Spatial Biology Segment ("DSS President") effective March 1, 2026.”
Affiliation history
-
BIO-TECHNE Corp (TECH)
SEC 8-K
Current2026-03-01–present
Company network
Leadership on record at BIO-TECHNE Corp
- Charles Kummeth CEO
- James T. Hippel CFO
- Kim Kelderman COO, Board Member
- Shane Bohnen General Counsel
- Alpna Seth Board Member
- Amy Herr Board Member
- Charles R. Kummeth Board Member
- Dr. Amy Herr Board Member
- Dr. Judith Klimovsky Board Member
- John L. Higgins Board Member